phenyl acetate has been researched along with prostaglandin d2 in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 8 (57.14) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Chao, W; Liu, H; Olson, MS | 1 |
Capobianco, E; Gonzalez, E; Jawerbaum, A; Pustovrh, C; Sinner, D; White, V | 1 |
Capobianco, E; Gonzalez, E; Higa, R; Jawerbaum, A; Martinez, N; Mugnaini, MT; Pustovrh, C; Romanini, MC; Soñez, C; White, V | 1 |
Hiyama, Y; Ishimura, M; Kataoka, S; Maeda, T; Suda, M | 1 |
Arai, I; Futaki, N; Hashimoto, Y; Honma, Y; Inoue, T; Koizumi, C; Nakaike, S; Nakanishi, Y; Ono, N; Sakurai, T; Sugimoto, M; Takahashi, N; Takaoka, A; Tanami, T; Yagi, M | 1 |
Arai, I; Futaki, N; Hashimoto, Y; Honma, Y; Nakaike, S; Sakurai, T; Sugimoto, M | 1 |
Bao, B; Choi, JS; Dang, HT; Hong, J; Jung, JH; Lee, HJ; Yoo, ES | 1 |
Abraham, WM; Arimura, A; Deguchi, M; Hirano, Y; Shichijo, M; Suzuki, N; Yasui, K | 1 |
Birtwistle, J; Bunce, CM; Davies, NJ; Hayden, RE; Mayer, K; Ride, JP; Simpson, PJ | 1 |
Akam, E; Bell, FM; Bonnert, RV; Dainty, IA; Dougall, IG; Heinemann, A; Marshall, C; Sargent, CA; Schmidt, JA | 1 |
Bauer, C; Bradley, ME; Charlton, SJ; Dubois, G; Miah, A; Reilly, J; Riddy, DM; Sandham, DA; Sykes, DA; Watson, SJ; Willard, E | 1 |
Aivazidis, A; Andersson, EM; Broberg, M; Ericsson, H; Hompesch, M; Kjaer, M; Löfgren, L; Morrow, L; Parkinson, J; Ryberg, E; Rydén-Bergsten, T; Schnecke, V; Skrtic, S; Sörhede Winzell, M; Tyrberg, B; Watkins, E; Wennberg Huldt, C | 1 |
Chichester, K; Devine, K; Oliver, ET; Saini, SS; Sterba, PM; Vonakis, BM; Wegner, C | 1 |
Aoyagi, H; Hirasawa, N; Kajiwara, D; Miyoshi, K; Tanaka, K; Tsunekuni, K | 1 |
2 trial(s) available for phenyl acetate and prostaglandin d2
Article | Year |
---|---|
Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
Topics: Acetates; Blood Glucose; C-Peptide; Cell Line; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Female; Gene Expression Regulation; Humans; Indoles; Insulin; Islets of Langerhans; Male; Middle Aged; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Transcription Factors | 2018 |
Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.
Topics: Acetates; Administration, Oral; Adult; Aged; Chronic Disease; Eosinophils; Female; Humans; Indoles; Male; Middle Aged; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; Urticaria | 2019 |
12 other study(ies) available for phenyl acetate and prostaglandin d2
Article | Year |
---|---|
Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide.
Topics: Acetates; Animals; Bucladesine; Calcium; Cell Line; Colforsin; Cycloheximide; Dactinomycin; Kinetics; Lipopolysaccharides; Macrophages; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandin D2; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1992 |
Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis.
Topics: Acetates; Analysis of Variance; Animals; Cholesterol; Cholesterol Esters; Culture Techniques; Diabetes Mellitus, Experimental; Female; Fetus; Lipid Metabolism; Lipids; Lipoproteins; Nitrates; Nitric Oxide; Nitrites; Organogenesis; Pregnancy; Pregnancy in Diabetics; Prostaglandin D2; Rats; Rats, Wistar; Triglycerides | 2002 |
15-Deoxy-Delta12,14-prostaglandin J2 and peroxisome proliferator-activated receptor gamma (PPARgamma) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARgamma agonist on nitridergic and lipid placental metabolism.
Topics: Acetates; Animals; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Experimental; Female; Gestational Age; Lipid Metabolism; Nitrates; Nitrites; Peroxynitrous Acid; Placenta; PPAR gamma; Pregnancy; Prostaglandin D2; Rats; Rats, Wistar; Streptozocin; Tyrosine | 2005 |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Acetylcholine; Albuterol; Animals; Atropine; Benzoquinones; Carbachol; Chromones; Cyclopropanes; Dinoprost; Drug Evaluation, Preclinical; Guinea Pigs; Heptanoic Acids; Histamine; In Vitro Techniques; Indoles; Indomethacin; Ketanserin; Ketotifen; Leukotriene Antagonists; Leukotriene D4; Male; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Powders; Procaterol; Prostaglandin Antagonists; Prostaglandin D2; Quinolines; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Substance P; Sulfides; Sulfonamides; Tosyl Compounds; Trachea; Tryptophan | 2006 |
Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Topics: Acetates; Animals; Antipruritics; Concanavalin A; Cyclohexanes; Cytokines; Dermatitis, Atopic; Dexamethasone; Humans; Hydantoins; Immunosuppressive Agents; Inflammation; Male; Mice; Platelet Aggregation; Prostaglandin D2; Pruritus; Receptors, Immunologic; Receptors, Prostaglandin; Skin; Sulfhydryl Compounds; Tacrolimus; Wound Healing | 2007 |
The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antipruritics; Arachidonic Acid; Cyclohexanes; Dermatitis, Atopic; Dexamethasone; Gene Expression Regulation; Male; Mice; Prostaglandin D2; Pruritus; Receptors, Prostaglandin; Skin; Sulfhydryl Compounds; Water Loss, Insensible | 2007 |
New jasmonate analogues as potential anti-inflammatory agents.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclopentanes; Interleukin-6; Lipopolysaccharides; Mice; Nitric Oxide; Oxylipins; Prostaglandin D2; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2008 |
A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
Topics: Acetates; Allergens; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cyclic AMP; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Prostaglandin D2; Quinolines; Receptors, Immunologic; Receptors, Prostaglandin; Sulfides; Thiophenes; Time Factors | 2009 |
AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects.
Topics: 20-Hydroxysteroid Dehydrogenases; Acetates; Cell Survival; Cells, Cultured; Cyclopentanes; Drug Delivery Systems; Drug Evaluation, Preclinical; Enzyme Inhibitors; HL-60 Cells; Humans; Hydroxyprostaglandin Dehydrogenases; Isoenzymes; Leukemia, Myeloid; Mitochondria; Models, Biological; Oxylipins; Prostaglandin D2; Reactive Oxygen Species | 2009 |
Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma.
Topics: Acetates; Administration, Oral; Animals; Anti-Asthmatic Agents; Basophils; Bone Marrow Cells; CD11b Antigen; Cell Shape; Chemotaxis, Leukocyte; Dogs; Eosinophils; Guinea Pigs; Humans; In Vitro Techniques; Indoles; Mice; Prostaglandin D2; Rabbits; Rats; Receptors, Prostaglandin; Species Specificity; Th2 Cells; Up-Regulation | 2013 |
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
Topics: Acetates; Animals; Anti-Allergic Agents; Binding, Competitive; Cell Shape; Cells, Cultured; CHO Cells; Cricetulus; Drugs, Investigational; Eosinophils; Humans; Indoleacetic Acids; Indoles; Kinetics; Ligands; Prostaglandin D2; Pyridines; Receptors, Immunologic; Receptors, Prostaglandin; Recombinant Proteins; Solubility; Th2 Cells; Tritium | 2016 |
Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis.
Topics: Acetates; Animals; Anti-Allergic Agents; Cell Line; Cyclopropanes; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Guinea Pigs; Humans; Intramolecular Oxidoreductases; Lipocalins; Male; Morpholines; Nasal Mucosa; Nasal Obstruction; Ovalbumin; Piperidines; Prostaglandin D2; Pyrroles; Quality of Life; Quinolines; Rats; Rhinitis, Allergic; Sulfides; Terfenadine | 2020 |